Edwards Lifesciences (EW) Intangibles (2009 - 2026)

Edwards Lifesciences has reported Intangibles for 18 years, with the latest figure at $1.4 billion in Q2 2026.

• On a quarterly basis, Intangibles rose 17.89% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 17.89% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 4.11% from the prior year.
• Intangibles was $1.4 billion for Q2 2026 at Edwards Lifesciences, up from $1.2 billion in the prior quarter.
• The five-year high for Intangibles was $1.4 billion in Q2 2026, with the low at $266.5 million in Q3 2022.
• Average Intangibles over 5 years is $728.6 million, with a median of $446.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Intangibles fell 18.08% in 2022, then soared 194.59% in 2024.
• Over 5 years, Intangibles stood at $285.2 million in 2022, then jumped by 40.04% to $399.4 million in 2023, then jumped by 194.59% to $1.2 billion in 2024, then slipped by 4.11% to $1.1 billion in 2025, then gained by 22.55% to $1.4 billion in 2026.
• The last three Intangibles figures came in at $1.4 billion (Q2 2026), $1.2 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.